Form 4 holding
Director
enGene Therapeutics Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 31,000
- Estimated value
- Report date
- 16 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount